Urachal signet-cell adenocarcinoma

Scandinavian Journal of Urology and Nephrology

Volumn 43, Issue 1, 2009, Pages 88-91

  Egevad, Lars ^a   Håkansson, Ulf ^b   Grabe, Magnus ^b   Ehrnström, Roy ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carcinoma; Human; Pathology; Signet cell; Urachus; Urinary bladder

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; DOXORUBICIN; FLUVOXAMINE; METHOTREXATE; OXALIPLATIN; VINBLASTINE;

ADIPOSE TISSUE; ADJUVANT THERAPY; ADULT; ARTICLE; ASCITES; BLADDER CARCINOMA; BLOOD; BONE METASTASIS; CANCER INVASION; CANCER RECURRENCE; CASE REPORT; CYSTECTOMY; CYSTOSCOPY; DETRUSOR MUSCLE; HEMATURIA; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; MULTIPLE CYCLE TREATMENT; PERITONEUM; PRIORITY JOURNAL; PROSTATE CANCER; TRANSURETHRAL RESECTION; URACHAL SIGNET CELL ADENOCARCINOMA;

CARCINOMA, SIGNET RING CELL; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; MALE; MIDDLE AGED; PROGNOSIS; URACHUS; URINARY BLADDER NEOPLASMS;

EID: 61649110537     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590802361914     Document Type: Article

References (17)

1. Sheldon CA, Clayman RV, Gonzalez R, Williams RD, Fraley EE. Malignant urachal lesions. J Urol 1984;131:1-8.
2. Daljeet S, Amreek S, Satish J, Raman A, Hara GS, Lovneesh G, et al. Signet ring cell adenocarcinoma of the urachus. Int J Urol 2004;11:785-8.
3. Merchant SH, Amin MB, Tamboli P, Ro J, Ordonez NG, Ayala AG, et al. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol 2001;25:1515-9.
4. Chu PG, Weiss LM. Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon. Am J Clin Pathol 2004;121:884-92.
5. Gonzalez-Lois C, Rodriguez-Peralto JL, Serrano-Pardo R, Martinez-Gonzalez MA, Lopez-Rios F. Cutaneous signet ring cell carcinoma: a report of a case and review of the literature. Am J Dermatopathol 2001;23:325-8.
6. Ro JY, el-Naggar A, Ayala AG, Mody DR, Ordonez NG. Signet-ring-cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases. Am J Surg Pathol 1988;12:453-60.
7. Ghannoum JE, Freedman PD. Signet-ring cell (mucin-producing) adenocarcinomas of minor salivary glands. Am J Surg Pathol 2004;28:89-93.
8. Suzuki K, Morita T, Tokue A. Primary signet ring cell carcinoma of female urethra. Int J Urol 2001;8:509-12.
9. Chen KT, Workman RD, Rainwater G. Urachal signet-ring cell carcinoma. Urology 1990;36:339-40.
10. Fiter L, Gimeno F, Martin L, Gomez Tejeda L. Signet-ring cell adenocarcinoma of bladder. Urology 1993;41:30-3.
11. Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol 1991;95:13-20.
12. Loggie BW, Fleming RA, Hosseinian AA. Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology 1997;50:446-8.
13. Antunes AA, Siqueira TM Jr, Falcao E. Vesical metastasis of gastric adenocarcinoma. Int Braz J Urol 2004;30:403-5.
14. Mangiacapra FJ, Scheraga JL, Jones LA. Mucinous colloid adenocarcinoma of the urachus. Radiographics 2001;21:965-9.
15. Suh N, Yang XJ, Tretiakova MS, Humphrey PA, Wang HL. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Mod Pathol 2005;18:1217-22.
16. Reis-Filho JS, Carrilho C, Valenti C, Leitao D, Ribeiro CA, Ribeiro SG, et al. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? Pathol Res Pract 2000;196:835-40.
17. Tian W, Osawa M, Horiuchi H, Tomita Y. Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate. Cancer Sci 2004;95:491-5.